跳至主要内容
临床试验/CTRI/2021/11/038185
CTRI/2021/11/038185招募中未知

Clinical Utility of a Circulating Tumor Cell Detection Test for Detection of Soild Organ Cancers in Asymptomatic Individuals

Datar Cancer Genetics Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Adult males and females, aged 30 years and above,
  • 2.Provision of Informed Consent ,
  • 3.Willing and able to participate in the study and provide blood sample.
  • 4.No co-morbidities which could impair study participation or procedures,
  • 5.Female participants: neither pregnant, nor lactating
  • 6.For Cohort A (Suspected Cases)
  • a.No prior diagnosis .of (any) cancer,
  • b.Presenting with symptoms or radiological I clinical findings suspected of solid
  • organ cancer (priority for localized cancer),
  • c.Biopsy nalve and posted to undergo tissue biopsy for histopathological examination (HPE) as part of standard diagnostic procedure,
  • d.Willing to share HPE findings for the study,
  • e.Optional: Willing for 1-year telephonic follow-up if diagnosed with nonÃ?­ malignant conditions.
  • 7.For Cohort B (Asymptomatic Individuals)
  • a.Baseline risk of cancer,
  • b.Non-smoker ,
  • c.No elevated risk of cancer associated with lifestyle, occupation or any other socioeconomic factors,
  • d.No diagnosis (or sympto ms suggestive) of chronic or new onset diabetes,
  • chronic pulmonary disease or chronic gastrointestinal disease,
  • e.Normal CBC, blood glucose, liver function test and kidney function test,
  • f.No family history of cancer,
  • g.No known genetic predisposition for cancer,
  • h.No prior diagnosis of (any) cancer,
  • i.No prior diagnosis of benign or chronic inflammatory conditions ,
  • j.. No current symptoms or radiological I clinical findings suspected of cancer or
  • benign conditions.
  • k.Optional: Willing for 1-year telephonic follow-up.

排除标准

  • 1.Failure to meet general cohort-specific Inclusion Criteria,
  • 2.Age less than 30 years ,
  • 3.Inability to provide Informed Consent,
  • 4.Co-morbidities which could impair study participation or sample collection,
  • 5.Current febrile illness,
  • 6.Chronic or acute inflammatory conditions within past 14 days,
  • 7.Positive for HIV/HBV/HCV,

研究者

相似试验